Description
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Trial to Evaluate the Efficacy and Safety of a Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia(ASPEN-1)
Please contact simr@sutterhealth.org about Study ASPEN-1 CD
Location: SIMR (Sacramento/Valley Area)
View study details on ClinicalTrials.govPrincipal Investigator
Recruitment Status
Active, Recruiting
Start Date
February 01, 2019
Related Studies
GXCA
Investigator: Lawrence Dickinson, M.D
Genetics and Comorbidity of Migraine
Investigator: Alice R. Pressman, Ph.D., M.S.
Mindfulness and Migraine: A Randomized Controlled Trial
Investigators: Sylvia Sudat, PhD, Alice R. Pressman, Ph.D., M.S.
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Investigator: Alice R. Pressman, Ph.D., M.S.